Iris BioTechnologies (IRSB) Stock Price, News & Analysis

Company Overview

Iris BioTechnologies, Inc., a life science company, develops solutions for the detection and monitoring of monogenic and complex genomic diseases. It is developing nano-biochip technology platform used for the diagnosis and treatment of patients with breast cancer, neurological disorders, heart diseases, diabetes, and other gene-related metabolic problems. The company also develops BioWindows, an artificial intelligence system, which provides data and analysis for clinical applications, drug development, and stem cell research. Iris BioTechnologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.04 to $0.41
• Volume: N/A
• Average Volume: 8,024 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IRSB Stock Analysis - Frequently Asked Questions

How have IRSB shares performed this year?

Iris BioTechnologies' stock was trading at $0.04 on January 1st, 2025. Since then, IRSB shares have increased by 0.0% and is now trading at $0.04.

How were Iris BioTechnologies' earnings last quarter?

Iris BioTechnologies Inc (OTCMKTS:IRSB) issued its earnings results on Tuesday, November, 15th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of Iris BioTechnologies?

Shares of IRSB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/15/2016
• Today: 9/20/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:IRSB
• Previous Symbol: NASDAQ:IRSB
• CIK: 1396238
• Web: www.irisbiotech.com
• Phone: +1-408-8672885
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A